CVI Investments, Inc. 13D and 13G filings for Citius Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 2:47 pm Purchase | 2025-12-31 | 13G | CITIUS PHARMACEUTICALS INC CTXR | CVI Investments, Inc. | 2,394,725 9.900% | 739,044 (+44.64%) | Filing |
| 2025-10-27 10:47 am Purchase | 2025-10-20 | 13G | CITIUS PHARMACEUTICALS INC CTXR | CVI Investments, Inc. | 1,655,681 9.900% | 1,655,681 (New Position) | Filing |